Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Steinberg

Showing results (321-330 of 481) with videos related to

Pageof 49
Sort By:
American Journal of Hematology|January 7, 2020
Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosisSencer Goklemez, Annie P Im, Liang Cao, et al.
Breast Cancer Research and Treatment|January 14, 2016
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and AxlJennifer L Dine, Ciara C O'Sullivan, Donna Voeller, et al.
Journal of Cancer|June 7, 2012
A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as BiomarkersRussell C Langan, John E Mullinax, Satyajit Ray, et al.
Cancer Research|January 5, 2012
Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damageDaniel P Fitzgerald, Preeti Subramanian, Monika Deshpande, et al.
The Lancet. Oncology|April 6, 2015
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker studyMark Roschewski, Kieron Dunleavy, Stefania Pittaluga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancerJames C Yang, Richard M Sherry, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccinesFranz O Smith, Stephanie G Downey, Jacob A Klapper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
A phase II clinical trial of sorafenib in androgen-independent prostate cancerWilliam L Dahut, Charity Scripture, Edwin Posadas, et al.
Cancer Medicine|October 8, 2022
Systemic immune changes accompany combination treatment with immunotoxin LMB-100 and nab-paclitaxelGuillaume Joe Pegna, Min-Jung Lee, Cody J Peer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2017
Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease PatientsLauren M Curtis, Filip Pirsl, Seth M Steinberg, et al.
Pageof 49

Showing results (321-330 of 481) with videos related to

Sort By:
Pageof 49
American Journal of Hematology|January 7, 2020
Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosisSencer Goklemez, Annie P Im, Liang Cao, et al.
Breast Cancer Research and Treatment|January 14, 2016
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and AxlJennifer L Dine, Ciara C O'Sullivan, Donna Voeller, et al.
Journal of Cancer|June 7, 2012
A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as BiomarkersRussell C Langan, John E Mullinax, Satyajit Ray, et al.
Cancer Research|January 5, 2012
Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damageDaniel P Fitzgerald, Preeti Subramanian, Monika Deshpande, et al.
The Lancet. Oncology|April 6, 2015
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker studyMark Roschewski, Kieron Dunleavy, Stefania Pittaluga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancerJames C Yang, Richard M Sherry, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccinesFranz O Smith, Stephanie G Downey, Jacob A Klapper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
A phase II clinical trial of sorafenib in androgen-independent prostate cancerWilliam L Dahut, Charity Scripture, Edwin Posadas, et al.
Cancer Medicine|October 8, 2022
Systemic immune changes accompany combination treatment with immunotoxin LMB-100 and nab-paclitaxelGuillaume Joe Pegna, Min-Jung Lee, Cody J Peer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2017
Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease PatientsLauren M Curtis, Filip Pirsl, Seth M Steinberg, et al.
Pageof 49